IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Indo US Bio-Tech IPO listing price is ₹ 57.80, issue price is [●], and currently trading at ₹ 171.49 as on May 30, 2025. Indo US Bio-Tech IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Indo US Bio-Tech IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Agro - Food Products sector. Swastika Investmart is the merchant banker of Indo US Bio-Tech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Indo US Bio-Tech IPO offer price is ₹ 51.00 and got listed at ₹ 57.80. Read Indo US Bio-Tech IPO details mentioned above.The IPO of Indo US Bio-Tech Limited was listed on 11th May 2018. As of today, Indo US Bio-Tech IPO is trading at ₹ 171.49, compared to the previous day’s close of ₹ 171.99. Read the report above for detailed IPO performance.
The issue price of Indo US Bio-Tech IPO was [●] per equity share.
Indo US Bio-Tech IPO was listed at ₹57.80 on the stock exchange on 11th May 2018. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Indo US Bio-Tech IPO is ₹ 171.49.
The 52-week high for Indo US Bio-Tech IPO is ₹ 388.40, while the 52-week low is ₹ 138.13. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Indo US Bio-Tech IPO listed at ₹ 57.80 against the issue price of [●] per equity share, showing a listing day gain/loss of 6.8 (13.33%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Indo US Bio-Tech IPO stock moved from its listing price of ₹ 57.80 to the current price of ₹171.49 per equity share, reflecting a change of 196.70% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Indo US Bio-Tech IPO issue date of May 30, 2025 and CMP of ₹171.49, the estimated CAGR is approximately 18.74%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
₹ 57.80
Previous Day Closing
₹ 171.99
Indo US Bio-Tech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Indo US Bio-Tech Financial Review Page
Merchant Banker(s) of Indo US Bio-Tech IPO: Swastika Investmart Limited
Indo US Bio-Tech IPO subscription was 19.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Indo US Bio-Tech IPO listed at a listing price of 57.80 against the offer price of 51.00.
The current market price of Indo US Bio-Tech is 171.49.
Why Us?
